Spots Global Cancer Trial Database for A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma
Official Title: A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma
Study ID: NCT01929265
Interventions
Study Description
Brief Summary: This is a prospective, multicenter phase II trial designed to determine efficacy and safety of a chemoimmunotherapy with the combination of Bendamustine + Rituximab in patients with advanced untreated Indolent non Follicular non-Hodgkin Lymphomas (INFL).
Detailed Description: This is a prospective, multicenter phase II trial designed to determine efficacy and safety of a chemoimmunotherapy with the combination of Bendamustine + Rituximab in patients with advanced untreated Indolent non Follicular non-Hodgkin Lymphomas (INFL). The study includes and induction phase and a consolidation phase.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
SC Ematologia - AO SS. Antonio e Biagio e C. Arrigo, Alessandria, AL, Italy
SC Ematologia Spedali Civili, Brescia, BS, Italy
Divisione di Ematologia e Trapianti, Ospedale San Maurizio, Bolzano, BZ, Italy
Divisione di Ematologia, Centro Trapianto di Cellule Staminali, San Giovanni Rotondo, Foggia, Italy
Divisione Ematologia I , Ospedale San Martino, Genova, GE, Italy
S.C. Ematologia Azienda Ospedaliera Papardo, Messina, ME, Italy
Divisione di Oncologia Medica ed Ematologia, Istituto Clinico Humanitas, Rozzano, Milano, Italy
Divisione di Ematologia Ospedale Niguarda, Milano, MI, Italy
Centro Oncologico Modenese, Modena, MO, Italy
Ematologia Azienda Ospedaliero Universitaria Paolo Giaccone, Palermo, PA, Italy
Div. Oncologia Medica - CRO, Centro di Riferimento Oncologico, Aviano, PN, Italy
UOC Ematologia 1/CTMO, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, , Italy
Oncoematologia Istituto Pascale, Napoli, , Italy
S.C.D.U Ematologia Azienda Ospedaliero Universitaria Maggiore, Novara, , Italy
UO Ematologia Università - Policlinico San Matteo, Pavia, , Italy
Ematologia Ospedale Santo Spirito, Pescara, , Italy
UOA Ematologia, Ospedale Civile Ospedale G. da Saliceto, Piacenza, , Italy
Div. Ematologia AO Bianchi Melacrino Morelli, Reggio Calabria, , Italy
Ematologia, Azienda Ospedaliera Arcispedale "S.Maria Nuova", Reggio Emilia, , Italy
Ematologia, Università "La Sapienza", Roma, , Italy
Clinica Ematologia Policlino Le Scotte, Siena, , Italy
Struttura Complessa di Onco-Ematologia Azienda Ospedaliera S.Maria, Terni, , Italy
SC Ematologia - Città della Salute e della Scienza, Torino, , Italy
SC Ematologia U - Città della Salute e della Scienza, Torino, , Italy
Clinica Ematologica e Unità di Terapie Cellulari 'Carlo Melzi' AOU S. Maria della Misericordia, Udine, , Italy
Contact Details
Name: Luca Baldini, Prof.
Affiliation: UOC Ematologia 1/CTMO, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
